Vivos Therapeutics Stock Market Value
| VVOS Stock | USD 3.38 0.18 5.62% |
| Symbol | Vivos |
Vivos Therapeutics Price To Book Ratio
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vivos Therapeutics. If investors know Vivos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vivos Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.99) | Revenue Per Share 6.877 | Quarterly Revenue Growth 0.194 | Return On Assets (0.57) | Return On Equity (2.85) |
The market value of Vivos Therapeutics is measured differently than its book value, which is the value of Vivos that is recorded on the company's balance sheet. Investors also form their own opinion of Vivos Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Vivos Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vivos Therapeutics' market value can be influenced by many factors that don't directly affect Vivos Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vivos Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Vivos Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vivos Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Vivos Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Vivos Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Vivos Therapeutics.
| 10/26/2024 |
| 11/25/2024 |
If you would invest 0.00 in Vivos Therapeutics on October 26, 2024 and sell it all today you would earn a total of 0.00 from holding Vivos Therapeutics or generate 0.0% return on investment in Vivos Therapeutics over 30 days. Vivos Therapeutics is related to or competes with Bone Biologics, Tivic Health, Bluejay Diagnostics, Rapid Micro, NanoVibronix, Nuwellis, and Heart Test. Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients ... More
Vivos Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Vivos Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Vivos Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 6.5 | |||
| Information Ratio | 0.0518 | |||
| Maximum Drawdown | 69.53 | |||
| Value At Risk | (7.14) | |||
| Potential Upside | 9.52 |
Vivos Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Vivos Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Vivos Therapeutics' standard deviation. In reality, there are many statistical measures that can use Vivos Therapeutics historical prices to predict the future Vivos Therapeutics' volatility.| Risk Adjusted Performance | 0.061 | |||
| Jensen Alpha | 0.4681 | |||
| Total Risk Alpha | (0.75) | |||
| Sortino Ratio | 0.0655 | |||
| Treynor Ratio | 0.8422 |
Vivos Therapeutics Backtested Returns
Vivos Therapeutics appears to be dangerous, given 3 months investment horizon. Vivos Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0722, which indicates the firm had a 0.0722% return per unit of risk over the last 3 months. By inspecting Vivos Therapeutics' technical indicators, you can evaluate if the expected return of 0.6% is justified by implied risk. Please review Vivos Therapeutics' Coefficient Of Variation of 1476.9, risk adjusted performance of 0.061, and Semi Deviation of 5.53 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Vivos Therapeutics holds a performance score of 5. The entity has a beta of 0.65, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Vivos Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Vivos Therapeutics is expected to be smaller as well. Please check Vivos Therapeutics' treynor ratio, expected short fall, as well as the relationship between the Expected Short fall and day median price , to make a quick decision on whether Vivos Therapeutics' existing price patterns will revert.
Auto-correlation | 0.68 |
Good predictability
Vivos Therapeutics has good predictability. Overlapping area represents the amount of predictability between Vivos Therapeutics time series from 26th of October 2024 to 10th of November 2024 and 10th of November 2024 to 25th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Vivos Therapeutics price movement. The serial correlation of 0.68 indicates that around 68.0% of current Vivos Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.68 | |
| Spearman Rank Test | -0.09 | |
| Residual Average | 0.0 | |
| Price Variance | 0.04 |
Vivos Therapeutics lagged returns against current returns
Autocorrelation, which is Vivos Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Vivos Therapeutics' stock expected returns. We can calculate the autocorrelation of Vivos Therapeutics returns to help us make a trade decision. For example, suppose you find that Vivos Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Vivos Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Vivos Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Vivos Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Vivos Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Vivos Therapeutics Lagged Returns
When evaluating Vivos Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Vivos Therapeutics stock have on its future price. Vivos Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Vivos Therapeutics autocorrelation shows the relationship between Vivos Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Vivos Therapeutics.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Vivos Stock Analysis
When running Vivos Therapeutics' price analysis, check to measure Vivos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vivos Therapeutics is operating at the current time. Most of Vivos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Vivos Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vivos Therapeutics' price. Additionally, you may evaluate how the addition of Vivos Therapeutics to your portfolios can decrease your overall portfolio volatility.